March 26, 2004






Effective Monday, March 29, 2004 all claims for sevalamer hydrochloride (Renagel®) will be denied at the point of sale. The denied claim response will be the PACE DUR error message “706 CH”; NCPDP error message “88 CH” accompanied by instructions to “Call the Help Desk”.


Medical exceptions for Renagel® will only be approved following receipt of documentation from the prescriber substantiating:


1.      A prior trial of phosphate lowering therapy with an inability to control phosphate.


2.      A calcium phosphate product equal to or greater than 70mg²/dl².


NOTE: Approved Renagel® medical exceptions will be for a maximum of 4800mg (6 capsules) per day.


Program Representatives are NOT authorized to grant medical exceptions in the absence of this documentation.





Questions may be directed to Provider Services at